U.S. Markets close in 5 hrs 22 mins

Nektar Therapeutics (NKTR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.98-0.23 (-1.45%)
As of 10:38AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 328.60
52 Week Low 313.63
50-Day Moving Average 317.81
200-Day Moving Average 320.48

Share Statistics

Avg Vol (3 month) 31.02M
Avg Vol (10 day) 31.11M
Shares Outstanding 5178.9M
Float 177.11M
% Held by Insiders 11.17%
% Held by Institutions 199.49%
Shares Short (Oct 14, 2020) 425.89M
Short Ratio (Oct 14, 2020) 422.77
Short % of Float (Oct 14, 2020) 429.04%
Short % of Shares Outstanding (Oct 14, 2020) 414.47%
Shares Short (prior month Sep 14, 2020) 425.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Aug 22, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin -264.25%
Operating Margin (ttm)-230.48%

Management Effectiveness

Return on Assets (ttm)-12.67%
Return on Equity (ttm)-30.52%

Income Statement

Revenue (ttm)162.5M
Revenue Per Share (ttm)0.92
Quarterly Revenue Growth (yoy)109.50%
Gross Profit (ttm)93.24M
EBITDA -359.81M
Net Income Avi to Common (ttm)-429.4M
Diluted EPS (ttm)-2.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.04B
Total Cash Per Share (mrq)5.8
Total Debt (mrq)156.77M
Total Debt/Equity (mrq)12.48
Current Ratio (mrq)9.29
Book Value Per Share (mrq)7.03

Cash Flow Statement

Operating Cash Flow (ttm)-355.84M
Levered Free Cash Flow (ttm)-194.12M